Jiangsu Kanion Pharmaceuti (600557.SS) traded flat 0 % during a 24 hours period ending at 07:39 PM Central Europe on Monday 26th. One Jiangsu Kanion Pharmaceuti stock can currently be bought for about CNY 12.58 on popular exchanges. Current supply of Jiangsu Kanion Pharmaceuti stocks is 566.4 mn. Jiangsu Kanion Pharmaceuti has a current market capitalization of CNY 7.1 bn and approximately CNY 76.1 mn worth of Jiangsu Kanion Pharmaceuti was traded on exchanges in the last 24 hours. Since last month end, Jiangsu Kanion Pharmaceuti has traded 2.54 % up. Simple moving average of last 200 days is at CNY 12.41. The highest price of past 52 weeks was recorded at CNY 16.61 on 11/17/2025. 52 weeks low was at CNY 10.69 on 06/29/2026.
Here is how related stocks have performed in the past 24 hours:
Longhua Tech Luoyang (300263.SZ) traded flat 0 % and now trades at CNY 8.01. Longhua Tech Luoyang has a market capitalisation of CNY 8.4 bn. Current price/earnings ratio for Longhua Tech Luoyang is 42.42.
Rizhao Port (600017.SS) traded flat 0 % and now trades at CNY 2.8. Rizhao Port has a market capitalisation of CNY 8.5 bn. Rizhao Port has a current price to earnings ratio of 18.1.
Omh Science (300486.SZ) traded flat 0 % and now trades at CNY 18.9. Current market capitalisation for Omh Science is CNY 8.5 bn. Omh Science has a current price to earnings ratio of 204.36.
Juneway Electronic Technol (301458.SZ) traded flat 0 % and now trades at CNY 31.5. Juneway Electronic Technol has a market capitalisation of CNY 8.5 bn. Current price/earnings ratio for Juneway Electronic Technol is 77.41. JUNEWAY ELECTRONIC TECHNOLOGY disclosed its 2026 third‑quarter results, reporting a notable increase in revenue and profitability across the first three quarters of the year. The company’s earnings per share rose, reflecting stronger operating performance. Cash generated from operations also climbed, while investment activities brought in additional funds. Shareholding data showed that the top ten institutional investors held a slightly reduced percentage of the company’s shares compared to the previous quarter, indicating a modest shift in institutional ownership. Overall, the company’s financial metrics, including net profit and operating cash flow, displayed upward trends, underscoring continued growth momentum for the period.
Bona Film (001330.SZ) traded flat 0 % and now trades at CNY 5.54. Bona Film has a market capitalisation of CNY 8.5 bn. BONA FILM GROUP CO LTD experienced a sharp decline in its stock price on 26 October, coinciding with the release of its first AI‑produced feature, “Sanxingdui: Future Past.” While the film attracted initial investor enthusiasm and brief trading spikes, audience turnout remained modest, with daily attendance figures falling below one viewer per screening. The company’s earnings report for the first half of 2026 highlighted a high gross margin for its AI‑driven productions, yet the revenue from this segment represented a small fraction of total sales. In the broader media sector, several other film and media stocks, including Ciwencinema and others, also fell, reflecting a broader downturn in the cultural‑media segment. The company continues to advance additional AI‑film projects, but market reception to its current offering has been tepid.
About Jiangsu Kanion Pharmaceuti
Jiangsu Kanion Pharmaceutical Co., Ltd. is a health care company based in Lianyungang, China that specializes in manufacturing and marketing traditional Chinese pharmaceutical preparations and healthcare products. The company’s product range includes capsules, electuaries, pills, and liquid medicines. You can find more information about the company and its offerings on their website, www.kanion.com , and they are listed on the Shanghai Stock Exchange. Their Initial Public Offering (IPO) date was September 18, 2002.